Performax Labs continues to refine its performance-driven lineup, routinely revisiting previously released supplements to stay ahead of the competition. That process has now reached one of its longer-running muscle builders, as the brand prepares to release an updated edition of MassMax. The new version keeps its original strength and growth focus intact while introducing a few noteworthy adjustments to enhance overall anabolic support.
One of the most notable changes in the 2026 edition of MassMax is the increase in rhaponticum carthamoides, now raised by over 40% to 500mg from the previous 350mg, reinforcing its role in strength and muscle growth. Epicatechin and atractylodes remain untouched at 250mg and half a gram in a full daily serving, respectively, continuing to support myostatin modulation and strengthening performance during intense workouts.
Performax Labs does have new additions to MassMax, including eucommia ulmoides extract, incorporated for its phytoandrogenic properties and support of anabolic pathways. RAGF-1 anemarrhena asphodeloides extract is another new entry on the facts panel, which, according to the brand, has research suggesting growth hormone receptor interaction and IGF-1 stimulation. Together, these updates broaden the hormonal and growth-support approach of MassMax, making for a better overall supplement for those looking to build muscle.
Performax Labs has taken its original MassMax, dropped a few ingredients, carried over some, and added some new components, all in the name of improving muscle growth and performance. The brand is long known for its intricate formulas and reliable results, and it has done that again in the new version of MassMax. The improved product will be available in the coming weeks, potentially lining up with the week of the Arnold Expo.
